Ir al contenido principal
  • Iniciar sesión
    Bienvenido.
    Mi cuenta
    Cierre de sesión

AvePoint, Inc. (AVPT) Previsión de existencias 2025 - Predicción y análisis del precio de la IA

AvePoint, Inc. (AVPT) Previsión del precio de las acciones de AI y análisis de inversiones

AvePoint, Inc. Gráfico de cotizaciones y análisis técnico

Loading AvePoint, Inc. gráfico interactivo de cotizaciones y análisis técnico...

AvePoint, Inc. (AVPT) - Análisis exhaustivo de valores e investigación de inversiones

Deep dive into AvePoint, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AvePoint, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Para AvePoint, Inc.: AvePoint, Inc. operates in the Technology sector, establishing it as a mid-cap growth opportunity.

AvePoint, Inc. (Símbolo bursátil: AVPT) es una empresa líder en el sector Technology. que opera específicamente en la industria Services-Prepackaged Software..

La organización emplea a unos 1295 profesionales en todo el mundo .

La empresa se ha consolidado como una oportunidad de mediana capitalización en crecimiento con sólidos fundamentos.

Understanding Financial Performance

Qué significan estas métricas: Key financial indicators showing AvePoint, Inc.'s revenue scale, profitability, market value, and shareholder returns.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para AvePoint, Inc.: With $417M in annual revenue and -3,5% net margin, the company demonstrates developing profitability.

Ingresos anuales: $417 millones generar un -3,5% margen de beneficio neto .

Capitalización bursátil: $3853 millones - Clasificado como valores de crecimiento de mediana capitalización con un perfil de riesgo-rentabilidad equilibrado.

Rentabilidad de los fondos propios (ROE): -162,1% - Por debajo de la media eficiencia de la rentabilidad para el accionista, lo que indica áreas de mejora operativa.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AvePoint, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Para AvePoint, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Desbloquea las predicciones de IA Premium para acceder a nuestras previsiones avanzadas de aprendizaje automático para la acción AvePoint, Inc., incluidos objetivos de precio a 7, 30 y 90 días con intervalos de confianza y evaluaciones de riesgo.

Understanding Market Position

What this analysis covers: AvePoint, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Para AvePoint, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.

AvePoint, Inc. compite estratégicamente en el altamente dinámico Services-Prepackaged Software mercado, Establecerse como una prometedora oportunidad de crecimiento de mediana capitalización con sólidos fundamentos y una cuota de mercado en expansión. .

La empresa demuestra una sólida eficiencia operativa a través de una fuerte generación de flujo de caja libre de $3 millones anuales.

La empresa mantiene un saludable 52,8% margen bruto, lo que indica un fuerte poder de fijación de precios y eficiencia operativa.

AvePoint, Inc. (AVPT) Análisis fundamental y datos sobre operaciones con información privilegiada (Informes financieros trimestrales)

Datos financieros trimestrales completos, tendencias de beneficios, transacciones con información privilegiada y participaciones institucionales de AvePoint, Inc. análisis de valores.

Cargando AvePoint, Inc. análisis fundamental exhaustivo y datos de información privilegiada...

Profundice en la salud financiera, las métricas de valoración y la eficiencia operativa de AvePoint, Inc. para tomar decisiones de inversión informadas.

Comprender las métricas de valoración

Qué significan estas métricas: Las métricas de valoración ayudan a determinar si las acciones AvePoint, Inc. tienen un precio justo en comparación con sus beneficios, activos y posición en el mercado.

Cómo leerlos: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Para AvePoint, Inc.: Con un PER de -86,48, el mercado ve las acciones potencialmente infravaloradas.

P/E Ratio -86,48x
P/B Ratio 16,54x
Market Cap $3853M
EPS $-0,05
Valor contable/acción $1,13
Ingresos/Acciones $1,61
Entender las métricas de rentabilidad

Qué significan estas métricas: Estos ratios miden la eficacia con la que AvePoint, Inc. convierte los ingresos en beneficios y genera rentabilidad para los accionistas.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para AvePoint, Inc.: Un ROE de -162,1% indica un margen de mejora en creación de valor para el accionista.

ROE -162,1%
ROA -24,4%
ROIC -162,3%
Gross Margin 52,8%
Operating Margin -1,1%
Net Margin -3,5%
EBT Margin -17,1%
Tax Rate 9,2%
Entender las métricas de salud financiera

Qué significan estas métricas: Estos ratios evalúan la capacidad de AvePoint, Inc. para hacer frente a las obligaciones a corto plazo y gestionar eficazmente los niveles de endeudamiento.

Cómo leerlos: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Para AvePoint, Inc.: Un ratio corriente de 3,01. indica una fuerte liquidez.

Current Ratio 3,01x
Quick Ratio 2,93x
D/E Ratio 0,04x
Financial Leverage 1,55x
Interest Coverage 2,3x
Entender las métricas del flujo de caja

Qué significan estas métricas: Las métricas de flujo de caja revelan la capacidad de AvePoint, Inc. para generar efectivo a partir de operaciones y financiar iniciativas de crecimiento.

Cómo leerlos: El flujo de caja operativo positivo es crucial. El flujo de caja libre muestra el dinero disponible para dividendos, recompras o inversiones.

Para AvePoint, Inc.: Flujo de caja libre de $3M proporciona flexibilidad para el rendimiento de los accionistas y las inversiones de crecimiento.

Operating Cash Flow $5M
Free Cash Flow $3M
Capital Spending $-2M
FCF/Sales 1,3%
CapEx/Sales 1,3%
Entender las métricas de eficiencia operativa

Qué significan estas métricas: Estos ratios miden la eficacia con la que AvePoint, Inc. utiliza sus activos y gestiona el capital circulante.

Cómo leerlos: Unos índices de rotación más elevados indican una utilización eficaz de los activos. Los periodos de cobro más cortos muestran una gestión eficaz del crédito.

Para AvePoint, Inc.: Una rotación de activos de 0,69x sugiere un margen de mejora en utilización de activos.

Asset Turnover 0,69x
Receivables Turnover 5,3x
Fixed Assets Turnover 58,3x
Días de ventas pendientes 69 días
Período Acreedores 9 días
Comprender los datos de los estados financieros

Qué significan estas métricas: Cifras clave de la cuenta de resultados y el balance de AvePoint, Inc. que muestran los resultados financieros absolutos.

Cómo leerlos: Los ingresos muestran la escala empresarial, mientras que los márgenes indican la rentabilidad. Las partidas del balance revelan la estructura financiera.

Para AvePoint, Inc.: Con unos ingresos anuales de 417M, AvePoint, Inc. demuestra un tamaño empresarial sólido.

Cuenta de resultados ($ Millones)
Ingresos totales $417M
Ingresos de explotación $3M
Ingresos netos $-9M
Gastos de I+D $45M
Gastos de venta, generales y administrativos $83M
Coste de los productos vendidos $80M
Hechos destacados del balance (% Of Assets)
Total Current Assets 86%
Cash & Short-term Investments 70%
Total Liabilities 35%
Short-term Debt 2%
Accounts Receivable 14%
Información sobre dividendos y accionistas
Shares Outstanding 203M
Métricas de crecimiento (interanual)
EPS Growth -0,3%

Última AvePoint, Inc. Noticias y análisis bursátiles

Noticias de última hora, informes de analistas y actualizaciones del mercado que afectan a la cotización de AvePoint, Inc. (AVPT) y a las perspectivas de inversión.

, fuente: Yahoo Finance

Beyond Secure. AvePoint is the global leader in data security, governance, and resilience, going beyond traditional solutions to ensure a robust data foundation and enable organizations everywhere to ...

, fuente: The National Law Review

AvePoint does not give any assurance that it will achieve its expectations. Unless the context otherwise indicates, references in this press release to the terms “AvePoint,” “the Company,” “we,” “our” ...

, fuente: Investing.com on MSN

SINGAPORE - AvePoint Inc. (NASDAQ: AVPT), a company specializing in data security, governance, and resilience, has applied to list its common stock on the Main Board of the Singapore Exchange ...

, fuente: The National Law Review

JERSEY CITY, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive ...

AvePoint, Inc. Competidores y análisis de pares - Technology Sector

Análisis comparativo de AvePoint, Inc. frente a sus homólogos y competidores del sector Technology, con previsiones basadas en IA y métricas financieras clave.

Empresa Código bursátil Previsión de IA a 90 días Capitalización bursátil (M USD) Ratio PER Ratio P/B
ACIW Unlock Forecast - 30 Days FREE Trial $5308M 21,1x 3,8x
ADBE Unlock Forecast - 30 Days FREE Trial $151689M 22,1x 13,3x
ADSK Unlock Forecast - 30 Days FREE Trial $63742M 61,0x 24,4x
AEYE Unlock Forecast - 30 Days FREE Trial $164M -61,5x 22,3x
AI Unlock Forecast - 30 Days FREE Trial $2190M -16,8x 2,7x
AIFF Unlock Forecast - 30 Days FREE Trial $39M -4,2x 7,5x
AILE Unlock Forecast - 30 Days FREE Trial $148M x 50,7x
AILEW Unlock Forecast - 30 Days FREE Trial $9M x 3,1x
AISP Unlock Forecast - 30 Days FREE Trial $94M x -7,3x
AISPW Unlock Forecast - 30 Days FREE Trial $17M x -1,3x
ALKT Unlock Forecast - 30 Days FREE Trial $2615M -75,9x 7,6x
ALRM Unlock Forecast - 30 Days FREE Trial $3576M 27,8x 4,5x
ALSAF Unlock Forecast - 30 Days FREE Trial $39M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
ALTR Unlock Forecast - 30 Days FREE Trial $0M 360,3x 0,0x
AMPL Unlock Forecast - 30 Days FREE Trial $0M -16,9x 0,0x
AMST Unlock Forecast - 30 Days FREE Trial $10M -2,6x 7,9x
ANSS Unlock Forecast - 30 Days FREE Trial $28149M 66,6x 5,0x
APCX Unlock Forecast - 30 Days FREE Trial $8M -0,8x 3,0x
APCXW Unlock Forecast - 30 Days FREE Trial $5M x 3,4x
API Unlock Forecast - 30 Days FREE Trial $1419M x 2,2x
APPF Unlock Forecast - 30 Days FREE Trial $0M 64,5x 0,0x
APPN Unlock Forecast - 30 Days FREE Trial $2827M -27,3x -56,8x
ASAN Unlock Forecast - 30 Days FREE Trial $3145M -12,4x 14,0x
ATHR Unlock Forecast - 30 Days FREE Trial $69M x 11,7x
AUID Unlock Forecast - 30 Days FREE Trial $54M -159,3x 7,0x
AVDX Unlock Forecast - 30 Days FREE Trial $2064M 1104,8x 3,0x
AVPT Unlock Forecast - 30 Days FREE Trial $3853M -86,5x 16,5x
AVPTW Unlock Forecast - 30 Days FREE Trial $1482M x 6,4x
AWRE Unlock Forecast - 30 Days FREE Trial $49M -8,1x 1,7x
BAND Unlock Forecast - 30 Days FREE Trial $462M -30,3x 1,2x
BASE Unlock Forecast - 30 Days FREE Trial $1350M -10,2x 10,9x
BB Unlock Forecast - 30 Days FREE Trial $2289M -11,9x 3,2x
BBAI Unlock Forecast - 30 Days FREE Trial $1803M -3,9x 6,8x
BIGC Unlock Forecast - 30 Days FREE Trial $404M -14,6x 10,6x
BILL Unlock Forecast - 30 Days FREE Trial $9589M -533,4x 2,4x
BKYI Unlock Forecast - 30 Days FREE Trial $5M -26,8x 0,6x
BL Unlock Forecast - 30 Days FREE Trial $3798M 43,2x 9,2x
BLIN Unlock Forecast - 30 Days FREE Trial $15M -2,4x 1,5x
BLKB Unlock Forecast - 30 Days FREE Trial $3358M 88,2x 38,2x
BLZE Unlock Forecast - 30 Days FREE Trial $137M -5,6x 3,2x
BMR Unlock Forecast - 30 Days FREE Trial $42M x 2,3x
BNIX Unlock Forecast - 30 Days FREE Trial $34M x -5,7x
BNIXR Unlock Forecast - 30 Days FREE Trial $1M x -0,1x
BNIXW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
BNZI Unlock Forecast - 30 Days FREE Trial $6M x 1,9x
BNZIW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
BOX Unlock Forecast - 30 Days FREE Trial $4696M 42,9x -16,8x
BRZE Unlock Forecast - 30 Days FREE Trial $3241M -36,2x 5,4x
BSQKZ Unlock Forecast - 30 Days FREE Trial $46199M 15,6x 2,1x
BSY Unlock Forecast - 30 Days FREE Trial $17542M 69,0x 15,1x
CANG Unlock Forecast - 30 Days FREE Trial $1174M x 0,3x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $6432M 396,6x 3,0x
CCLD Unlock Forecast - 30 Days FREE Trial $146M 13,0x 2,6x
CCLDO Unlock Forecast - 30 Days FREE Trial $906M 80,4x 16,2x
CCLDP Unlock Forecast - 30 Days FREE Trial $822M -14,2x 16,5x
CCRD Unlock Forecast - 30 Days FREE Trial $226M 76,0x 4,2x
CCSI Unlock Forecast - 30 Days FREE Trial $529M 6,5x -8,3x
CDNS Unlock Forecast - 30 Days FREE Trial $92508M 91,4x 18,5x
CERT Unlock Forecast - 30 Days FREE Trial $1721M 215,6x 1,6x
CFLT Unlock Forecast - 30 Days FREE Trial $6455M -15,7x 7,7x
CGNT Unlock Forecast - 30 Days FREE Trial $711M x 3,6x
CHKP Unlock Forecast - 30 Days FREE Trial $22028M x 7,9x
CLBT Unlock Forecast - 30 Days FREE Trial $4265M x 10,4x
CLPS Unlock Forecast - 30 Days FREE Trial $13M x 0,8x
COUR Unlock Forecast - 30 Days FREE Trial $1774M -14,2x 2,8x
CRM Unlock Forecast - 30 Days FREE Trial $234323M 35,2x 3,8x
CRNC Unlock Forecast - 30 Days FREE Trial $398M -0,5x 2,6x
CRWD Unlock Forecast - 30 Days FREE Trial $106941M 4606,3x 28,5x
CRWV Unlock Forecast - 30 Days FREE Trial $62076M x 23,4x
CTV Unlock Forecast - 30 Days FREE Trial $466M -21,6x 2,3x
CVLT Unlock Forecast - 30 Days FREE Trial $7990M 98,6x 21,9x
CWAN Unlock Forecast - 30 Days FREE Trial $5165M 12,7x 2,6x
CXAI Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
CXAIW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
CXM Unlock Forecast - 30 Days FREE Trial $2084M 17,3x 3,8x
CYBR Unlock Forecast - 30 Days FREE Trial $23174M x 9,8x
DAY Unlock Forecast - 30 Days FREE Trial $11146M 227,5x 4,1x
DBX Unlock Forecast - 30 Days FREE Trial $0M 17,8x 0,0x
DDD Unlock Forecast - 30 Days FREE Trial $392M -3,9x 1,6x
DDOG Unlock Forecast - 30 Days FREE Trial $50266M 403,5x 15,7x
DH Unlock Forecast - 30 Days FREE Trial $595M -1,3x 2,0x
DOCU Unlock Forecast - 30 Days FREE Trial $16700M 59,4x 8,4x
DOMO Unlock Forecast - 30 Days FREE Trial $0M -3,7x 0,0x
DRTTF Unlock Forecast - 30 Days FREE Trial $102M 26,4x 3,0x
DSGX Unlock Forecast - 30 Days FREE Trial $9274M x 6,2x
DT Unlock Forecast - 30 Days FREE Trial $14496M 29,4x 5,4x
DTSS Unlock Forecast - 30 Days FREE Trial $16M -6,8x 5,5x
DUOL Unlock Forecast - 30 Days FREE Trial $13944M 119,0x 14,3x
DUOT Unlock Forecast - 30 Days FREE Trial $91M -2,8x 17,8x
EA Unlock Forecast - 30 Days FREE Trial $43249M 41,5x 7,1x
EGAN Unlock Forecast - 30 Days FREE Trial $220M 76,2x 4,3x
ENFN Unlock Forecast - 30 Days FREE Trial $0M 277,3x 0,0x
ESTC Unlock Forecast - 30 Days FREE Trial $10000M 24,9x 12,3x
EVCM Unlock Forecast - 30 Days FREE Trial $2172M -59,0x 2,9x
EXFY Unlock Forecast - 30 Days FREE Trial $176M -12,3x 1,3x
FAAS Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
FAASW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
FALC Unlock Forecast - 30 Days FREE Trial $1M x x
FATN Unlock Forecast - 30 Days FREE Trial $81M x 4,0x
FCUL Unlock Forecast - 30 Days FREE Trial $11M x 233,2x
FNGR Unlock Forecast - 30 Days FREE Trial $89M -16,8x 5,5x
FROG Unlock Forecast - 30 Days FREE Trial $5784M -60,2x 7,0x
FRSH Unlock Forecast - 30 Days FREE Trial $3872M -49,0x 3,9x
FRSX Unlock Forecast - 30 Days FREE Trial $1614M x 272,2x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1062M -8,6x 1,1x
GDYN Unlock Forecast - 30 Days FREE Trial $888M 2810,7x 1,7x
GEG Unlock Forecast - 30 Days FREE Trial $122M 9,5x 1,7x
GEGGL Unlock Forecast - 30 Days FREE Trial $1098M 85,2x 15,6x
GEN Unlock Forecast - 30 Days FREE Trial $18787M 27,7x 8,3x
GENVR Unlock Forecast - 30 Days FREE Trial $5663M x 2,5x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6194M x 6,9x
GMGI Unlock Forecast - 30 Days FREE Trial $146M -247,8x 1,2x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0,1x x
GTLB Unlock Forecast - 30 Days FREE Trial $8519M 654,1x 9,8x
GTM Unlock Forecast - 30 Days FREE Trial $3481M x 2,1x
GWRE Unlock Forecast - 30 Days FREE Trial $21674M 626,2x 15,9x
GXAI Unlock Forecast - 30 Days FREE Trial $11M -1,3x 0,7x
HPAI Unlock Forecast - 30 Days FREE Trial $147M x 9,0x
HUBS Unlock Forecast - 30 Days FREE Trial $25780M -5033,1x 12,5x
ICCT Unlock Forecast - 30 Days FREE Trial $34M x -11,4x
IDAI Unlock Forecast - 30 Days FREE Trial $8M -0,7x 3,2x
IDN Unlock Forecast - 30 Days FREE Trial $102M -52,1x 5,8x
INFA Unlock Forecast - 30 Days FREE Trial $7507M 3931,5x 3,2x
INLX Unlock Forecast - 30 Days FREE Trial $51M 1318,3x 4,4x
INSE Unlock Forecast - 30 Days FREE Trial $273M 4,5x -116,0x
INTA Unlock Forecast - 30 Days FREE Trial $3644M -173,7x 7,0x
INTU Unlock Forecast - 30 Days FREE Trial $185722M 48,0x 9,4x
IVDA Unlock Forecast - 30 Days FREE Trial $6M -7,5x 0,8x
IVDAW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
JAMF Unlock Forecast - 30 Days FREE Trial $1277M -22,8x 1,7x
KC Unlock Forecast - 30 Days FREE Trial $63341M x 6,7x
KLTR Unlock Forecast - 30 Days FREE Trial $237M 17,7x 14,0x
KVYO Unlock Forecast - 30 Days FREE Trial $8717M -19,1x 8,0x
LAW Unlock Forecast - 30 Days FREE Trial $344M -12,7x 2,5x
LFLY Unlock Forecast - 30 Days FREE Trial $1M -0,3x -4,0x
LFLYW Unlock Forecast - 30 Days FREE Trial $1M x -0,1x
LGTY Unlock Forecast - 30 Days FREE Trial $441M 27,8x 3,4x
LPSN Unlock Forecast - 30 Days FREE Trial $90M -0,5x -1,2x
LTESF Unlock Forecast - 30 Days FREE Trial $0M x x
LTRY Unlock Forecast - 30 Days FREE Trial $11M -0,1x 0,4x
LTRYW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
MANH Unlock Forecast - 30 Days FREE Trial $13015M 58,9x 46,7x
MAPS Unlock Forecast - 30 Days FREE Trial $174M -10,7x 5,9x
MAPSW Unlock Forecast - 30 Days FREE Trial $5M x 0,2x
MBLY Unlock Forecast - 30 Days FREE Trial $11271M -9,4x 0,9x
MDB Unlock Forecast - 30 Days FREE Trial $18161M -85,8x 6,0x
MGIC Unlock Forecast - 30 Days FREE Trial $1047M x 5,0x
MKTW Unlock Forecast - 30 Days FREE Trial $0M 6,0x 0,0x
MLNK Unlock Forecast - 30 Days FREE Trial $1523M -46,1x 3,9x
MNDY Unlock Forecast - 30 Days FREE Trial $9957M x 8,4x
MQ Unlock Forecast - 30 Days FREE Trial $2866M 51,0x 3,4x
MSFT Unlock Forecast - 30 Days FREE Trial $3735262M 36,7x 10,9x
MSGM Unlock Forecast - 30 Days FREE Trial $0M -0,7x 0,0x
MTBLY Unlock Forecast - 30 Days FREE Trial $1614M x 33,4x
MTTR Unlock Forecast - 30 Days FREE Trial $1763M -5,6x 4,4x
MYPS Unlock Forecast - 30 Days FREE Trial $122M -24,1x 0,5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0,4x 0,0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0,3x 0,5x
NABL Unlock Forecast - 30 Days FREE Trial $1538M 537,3x 1,9x
NCNO Unlock Forecast - 30 Days FREE Trial $3495M -119,0x 3,3x
NCSYF Unlock Forecast - 30 Days FREE Trial $9446M x 2,6x
NET Unlock Forecast - 30 Days FREE Trial $0M -419,2x 0,0x
NICE Unlock Forecast - 30 Days FREE Trial $9339M x 2,6x
NOW Unlock Forecast - 30 Days FREE Trial $193343M 116,4x 17,7x
NTNX Unlock Forecast - 30 Days FREE Trial $14701M -280,8x -21,5x
NTWK Unlock Forecast - 30 Days FREE Trial $45M 32,6x 1,3x
OKTA Unlock Forecast - 30 Days FREE Trial $0M -430,9x 0,0x
ONTF Unlock Forecast - 30 Days FREE Trial $234M -6,7x 1,6x
ORCL Unlock Forecast - 30 Days FREE Trial $684063M 36,4x 33,5x
OS Unlock Forecast - 30 Days FREE Trial $5659M x 14,7x
PATH Unlock Forecast - 30 Days FREE Trial $6295M 312,1x 3,8x
PAYC Unlock Forecast - 30 Days FREE Trial $12441M 29,9x 6,9x
PCOR Unlock Forecast - 30 Days FREE Trial $10276M -134,0x 8,4x
PCTY Unlock Forecast - 30 Days FREE Trial $9571M 42,1x 7,8x
PD Unlock Forecast - 30 Days FREE Trial $1639M -23,5x 9,1x
PDFS Unlock Forecast - 30 Days FREE Trial $923M -1123,7x 3,7x
PDYN Unlock Forecast - 30 Days FREE Trial $453M -3,0x 16,0x
PDYNW Unlock Forecast - 30 Days FREE Trial $4M 0,0x 0,1x
PLTR Unlock Forecast - 30 Days FREE Trial $433460M 567,9x 73,1x
PRCH Unlock Forecast - 30 Days FREE Trial $152M 2,7x -22,8x
PRGS Unlock Forecast - 30 Days FREE Trial $1903M 33,1x 4,2x
PTC Unlock Forecast - 30 Days FREE Trial $24707M 48,2x 7,0x
PYCR Unlock Forecast - 30 Days FREE Trial $4088M -69,4x 3,1x
QLYS Unlock Forecast - 30 Days FREE Trial $4821M 26,1x 9,5x
QTWO Unlock Forecast - 30 Days FREE Trial $5334M 1092,2x 9,1x
QUBT Unlock Forecast - 30 Days FREE Trial $2593M -23,3x 11,7x
RBLX Unlock Forecast - 30 Days FREE Trial $88022M -35,7x 249,2x
RBRK Unlock Forecast - 30 Days FREE Trial $15602M x 0,0x
RCAT Unlock Forecast - 30 Days FREE Trial $1025M -91,1x 35,4x
RDVT Unlock Forecast - 30 Days FREE Trial $736M 84,6x 7,7x
RPD Unlock Forecast - 30 Days FREE Trial $1268M 49,7x 14,0x
RTCJF Unlock Forecast - 30 Days FREE Trial $35M x 1,3x
S Unlock Forecast - 30 Days FREE Trial $5878M -25,6x 3,9x
SAIL Unlock Forecast - 30 Days FREE Trial $11026M -73,2x 1,6x
SBET Unlock Forecast - 30 Days FREE Trial $1064M x 2,4x
SCWX Unlock Forecast - 30 Days FREE Trial $0M -9,8x 0,0x
SEMR Unlock Forecast - 30 Days FREE Trial $1124M 169,4x 4,0x
SHOP Unlock Forecast - 30 Days FREE Trial $186064M x 15,4x
SKIL Unlock Forecast - 30 Days FREE Trial $136M -1,4x 2,2x
SMAR Unlock Forecast - 30 Days FREE Trial $4014M -19,6x 8,5x
SMSI Unlock Forecast - 30 Days FREE Trial $14M -0,2x 0,6x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7,0x 0,0x
SNOW Unlock Forecast - 30 Days FREE Trial $0M -54,7x 0,0x
SNPS Unlock Forecast - 30 Days FREE Trial $71917M 36,0x 2,6x
SOUN Unlock Forecast - 30 Days FREE Trial $15M -10,2x -27,1x
SOUNW Unlock Forecast - 30 Days FREE Trial $M x x
SPNS Unlock Forecast - 30 Days FREE Trial $2414M x 5,0x
SPSC Unlock Forecast - 30 Days FREE Trial $4209M 50,8x 4,4x
SPT Unlock Forecast - 30 Days FREE Trial $0M -27,5x 0,0x
SQ Unlock Forecast - 30 Days FREE Trial $0M 68,5x 0,0x
SSNC Unlock Forecast - 30 Days FREE Trial $22666M 28,1x 3,3x
SSTI Unlock Forecast - 30 Days FREE Trial $157M -38,0x 2,1x
SVCO Unlock Forecast - 30 Days FREE Trial $159M x 2,0x
SWI Unlock Forecast - 30 Days FREE Trial $3173M 86,3x 2,3x
TAOP Unlock Forecast - 30 Days FREE Trial $20M x 1,3x
TDC Unlock Forecast - 30 Days FREE Trial $2057M 18,7x 11,7x
TEAM Unlock Forecast - 30 Days FREE Trial $45635M -233,9x 33,9x
TENB Unlock Forecast - 30 Days FREE Trial $3609M -81,5x 10,3x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $10421M x 7,0x
TTWO Unlock Forecast - 30 Days FREE Trial $45001M -9,7x 12,9x
TWLO Unlock Forecast - 30 Days FREE Trial $16756M 827,7x 2,1x
TYL Unlock Forecast - 30 Days FREE Trial $26284M 85,7x 7,2x
U Unlock Forecast - 30 Days FREE Trial $19523M -13,5x 6,1x
UPLD Unlock Forecast - 30 Days FREE Trial $55M -1,2x -1,5x
VBIX Unlock Forecast - 30 Days FREE Trial $32M x 7,1x
VEEV Unlock Forecast - 30 Days FREE Trial $45933M 56,7x 6,9x
VERX Unlock Forecast - 30 Days FREE Trial $0M -368,3x 0,0x
VPRB Unlock Forecast - 30 Days FREE Trial $M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6327M -27,4x 18,5x
VWAV Unlock Forecast - 30 Days FREE Trial $25M x x
WBSR Unlock Forecast - 30 Days FREE Trial $M x x
WEAV Unlock Forecast - 30 Days FREE Trial $596M -36,7x 7,6x
WFCF Unlock Forecast - 30 Days FREE Trial $64M 31,4x 6,5x
WHEN Unlock Forecast - 30 Days FREE Trial $411M x 303,5x
WIMI Unlock Forecast - 30 Days FREE Trial $707M x 0,6x
WK Unlock Forecast - 30 Days FREE Trial $0M -70,2x 0,0x
XPER Unlock Forecast - 30 Days FREE Trial $350M -4,3x 0,8x
XYZ Unlock Forecast - 30 Days FREE Trial $46177M 15,6x 2,1x
YOU Unlock Forecast - 30 Days FREE Trial $2403M -51,2x 18,6x
ZDGE Unlock Forecast - 30 Days FREE Trial $42M -4,8x 1,5x
ZETA Unlock Forecast - 30 Days FREE Trial $4053M -26,5x 6,0x
ZI Unlock Forecast - 30 Days FREE Trial $3183M 346,5x 1,9x
ZSPC Unlock Forecast - 30 Days FREE Trial $37M x -3,2x
ZUO Unlock Forecast - 30 Days FREE Trial $0M -32,2x 0,0x

Preguntas frecuentes - AvePoint, Inc. Previsión de existencias

¿Hasta qué punto son precisas las predicciones bursátiles de AvePoint, Inc.?

Our AI model demonstrates 59% historical accuracy for AVPT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

¿Qué factores influyen en las previsiones AvePoint, Inc. del precio de las acciones?

Nuestro análisis tiene en cuenta las métricas financieras de AvePoint, Inc., las tendencias del sector Technology, el sentimiento del mercado, los indicadores técnicos, los datos de beneficios y los factores macroeconómicos que afectan al rendimiento de las acciones.

¿Es AvePoint, Inc. una buena inversión en 2025?

Según nuestro análisis de IA, AvePoint, Inc. muestra potencial para diversos escenarios de mercado. Considere su tolerancia al riesgo, el plazo de inversión y la diversificación de la cartera antes de tomar decisiones de inversión.

¿Con qué frecuencia se actualizan las previsiones AvePoint, Inc.?

Las previsiones bursátiles de AvePoint, Inc. se actualizan a diario utilizando datos de mercado en tiempo real, lo que garantiza que reciba las predicciones y perspectivas de inversión más actuales basadas en IA.

¿Desea un análisis AvePoint, Inc. más avanzado?

Desbloquee las funciones premium, incluidos los objetivos de precios detallados, las evaluaciones de riesgo, la optimización de la cartera y las alertas en tiempo real para las acciones AvePoint, Inc..

🎯 Análisis Premium 📊 Más acciones

Mi cartera

Panel de inversiones

Cargando su cartera...